Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Seroprevalence of Bordetella pertussis antibodies to pertussis toxin among healthy children.

Syed MA, Ahmed W, Naeem A, Bokhari H.

J Coll Physicians Surg Pak. 2012 Oct;22(10):677-8. doi: 10.2012/JCPSP.677678.

PMID:
23058160
2.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group.

Pediatrics. 2001 Nov;108(5):E81.

PMID:
11694665
3.

Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia.

Campbell P, McIntyre P, Quinn H, Hueston L, Gilbert GL, McVernon J.

PLoS One. 2012;7(4):e35874. doi: 10.1371/journal.pone.0035874. Epub 2012 Apr 27.

4.

Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.

Cevik M, Beyazova U, Aral AL, Duyan Camurdan A, Ozkan S, Sahin F, Aybay C.

Clin Microbiol Infect. 2008 Apr;14(4):388-90. doi: 10.1111/j.1469-0691.2007.01926.x. Epub 2008 Jan 7.

5.

Prevalence of high antibody titers of pertussis in Turkey: reflection of circulating microorganism and a threat to infants.

Esen B, Coplu N, Kurtoglu D, Gozalan A, Akin L.

J Clin Lab Anal. 2007;21(3):154-61.

PMID:
17506474
6.

Seroprevalence of pertussis in Senegal: a prospective study.

Gaayeb L, Sarr JB, Ndiath MO, Hanon JB, Debrie AS, Seck M, Schacht AM, Remoué F, Hermann E, Riveau G.

PLoS One. 2012;7(10):e48684. doi: 10.1371/journal.pone.0048684. Epub 2012 Oct 31.

7.

Seroprevalence of IgG antibodies to pertussis toxin in the Slovene population.

Socan M, Prosenc K, Vegnuti M.

Wien Klin Wochenschr. 2006 Jun;118(11-12):336-40.

PMID:
16855922
8.

Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins.

Hendrikx LH, Oztürk K, de Rond LG, Veenhoven RH, Sanders EA, Berbers GA, Buisman AM.

Vaccine. 2011 Feb 4;29(7):1431-7. doi: 10.1016/j.vaccine.2010.12.033. Epub 2010 Dec 25.

PMID:
21187178
9.

Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.

Hendrikx LH, de Rond LG, Oztürk K, Veenhoven RH, Sanders EA, Berbers GA, Buisman AM.

Vaccine. 2011 Aug 5;29(34):5725-30. doi: 10.1016/j.vaccine.2011.05.094. Epub 2011 Jun 12.

PMID:
21669247
10.

The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study.

Zhang Q, Zheng H, Liu M, Han K, Shu J, Wu C, Xu N, He Q, Luo H.

BMC Infect Dis. 2012 Jun 20;12:138.

11.

[Humoral imunity to pertussis in children with diabetes of type 1].

Tarasova AA, Kostinov MP, Zaĭtsev EM.

Zh Mikrobiol Epidemiol Immunobiol. 2006 May-Jun;(3):53-7. Russian.

PMID:
16830591
12.

Pertussis seroimmunity among mother-infant pairs and infant immune response to pertussis vaccination.

Saffar MJ, Ajami A, Khalilian AR, Qaheri A, Saffar H.

Indian Pediatr. 2007 Dec;44(12):916-8.

13.

Bordetella pertussis IgG and IgA antibodies seroprevalence among 1-35 y-old population: the role of subclinical pertussis infection.

Saffar MJ, Khalilian AR, Rafee AR, Parsaei MR, Imanikhani S, Shojaei J, Saffar H.

Indian J Pediatr. 2012 Mar;79(3):353-7. doi: 10.1007/s12098-011-0593-8. Epub 2011 Nov 22.

PMID:
22105235
14.

[Contents of antibodies to Bordetella pertussis antigens in patients with rheumatic diseases].

Kostinov MP, Tarasova AA, Zaĭtsev EM.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Nov-Dec;(6):61-4. Russian.

PMID:
18277540
15.

Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination.

Wanlapakorn N, Ngaovithunvong V, Thongmee T, Vichaiwattana P, Vongpunsawad S, Poovorawan Y.

PLoS One. 2016 Feb 2;11(2):e0148338. doi: 10.1371/journal.pone.0148338. eCollection 2016.

16.

Seroprevalence of Bordetella pertussis immunoglobulin G antibodies among children in Samsun, Turkey.

Ozkal A, Sensoy G, Acuner C, Belet N, Güney AK.

Turk J Pediatr. 2012 Jan-Feb;54(1):15-9.

PMID:
22397036
17.

Comparative seroepidemiology of pertussis, diphtheria and poliovirus antibodies in Singapore: waning pertussis immunity in a highly immunized population and the need for adolescent booster doses.

Lai FY, Thoon KC, Ang LW, Tey SH, Heng D, Cutter JL, Phoon MC, Chow VT.

Vaccine. 2012 May 21;30(24):3566-71. doi: 10.1016/j.vaccine.2012.03.059. Epub 2012 Apr 1.

PMID:
22475863
18.

Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants.

Gonik B, Puder KS, Gonik N, Kruger M.

Infect Dis Obstet Gynecol. 2005 Jun;13(2):59-61.

19.

Serological responses to infection with B. pertussis.

Giammanco A, Taormina S, Genovese M, Mangiaracina G, Giammanco G, Chiarini A.

Dev Biol Stand. 1997;89:213-20.

PMID:
9272353
20.

Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program.

Hallander HO, Andersson M, Gustafsson L, Ljungman M, Netterlid E.

APMIS. 2009 Dec;117(12):912-22. doi: 10.1111/j.1600-0463.2009.02554.x.

Supplemental Content

Support Center